FLT1 and breast carcinoma: The breast cancer cell line MCF-7 has been described with a survival system by which VEGF can act as an internal autocrine (intracrine) survival factor through its binding to VEGFR-1 [78], and cell line is sensitive to treatment with sorafenib, which also appear to down-regulate hypoxia induced HIF-1α expression [79].